Synthesis and spectroscopic properties of some new seven-coordinate thioacetamide complexes of molybdenum(II) and tungsten(II)

The compounds [MI₂(CO)₃(NCMe)₂] (M = Mo or W) react with one equivalent of SC(NH₂)Me in CH₂Cl₂ at room temperature to initially give the acetonitrile substituted products [MI₂(CO)₃(NCMe)- {SC(NH₂)Me}] which was isolated for M = W. However, the molybdenum complex rapidly dimerizes with loss of acetonitrile to give the iodide-bridged compound [Mo(σ-I)I(CO)₃ {SC(NH₂)Me}]₂. The tungsten complex does not appear to dimerize, even after stirring at room temperature for 72 h in CH₂Cl₂. Two equivalents of thioacetamide react with [MI₂- (CO)₃(NCMe)₂] in CH₂Cl₂ at room temperature to give the new bisthioacetamide compounds [MI₂- (CO)₃{SC(NH₂)Me}₂] via displacement of the labile acetonitrile ligands. The low temperature (−70 °C) ¹³C NMR spectrum of [WI₂(CO)₃{SC(NH₂)Me}₂] indicates that the geometry of the complex is capped octahedral with a carbonyl ligand in the unique capping position.     

Model studies for molybdenum enzymes. The reduction of cytochrome c by molybdenum(V)-cysteine complexes.

The reduction of ferricytochrome c by two molybdenum(V)-cysteine complexes has been investigated as a model for electron transfer in the molybdenum enzymes sulfite oxidase and nitrate reductase. The reduction by the dioxo-bridged Mo(V)-cysteine complex, di-mu-oxo-bis-[oxo(L-cysteinato)molybdate(V)] (I), is relatively slow and its rate is first order in cyt cIII and zero order in I (k = (1.09 +/- 0.10) times 10(-3) sec minus 1, pH 7.5, 20 degrees). The reduction by the monoxo-bridged complex, mu-oxo-bis[oxodihydroxo(L-cysteinato)molybdate(V)] (II), is extremely rapid and its rate is first order in both reactants (k = (2.6 +/- 0.7) times 10(7) M minus 1 sec minus 1, pH 7.0, 25 degrees). Above pH 7.5, the reduction by II follows biphasic kinetics due to the fast reduction of a low pH form of cyt cIII and a slower reduction of a high pH form (at pH 10.0, 25 degrees, k = 2.9 times 10(6) M minus 1 sec minus 1 for the low pH form and k = 7.2 times 10(4) M minus 1 sec minus 1 for the high pH form). Reaction mechanisms for reductions by both I and II are proposed and the biological implications of the results, both for sulfite oxidase and mechanisms of electron transfer to cytochrome c, are discussed.     

Synthesis and spectroscopic studies of mono(cyclopentadienyl)titanium(IV) derivatives with heterocyclic thioketones

The reactions of mono(cyclopentadienyl)titanium(IV) trichloride with two different classes of heterocyclic thioketones viz. 1-substituted-2-thiohydantoins and 1-substituted tetrazoline-5-thione were studied in anhydrous dichloromethane. The reaction products were characterized on the basis of elemental analyses electrical conductance, magnetic susceptibility and spectral (electronic, infrared and ¹H NMR) data.     

Electron paramagnetic resonance, kinetics of formation and decomposition studies of (bis(hydroxyethyl)amino-tris(hydroxymethyl)-methane)oxochromate(V): a model chromium(V) complex for DNA damage studies

A new chromium complex, (bis(hydroxyethyl)amino-tris(hydroxymethyl)methane)oxochromate(V), has been characterized by epr spectroscopy. The chromium(V) complex was formed by the ligand displacement reaction of bis(2-ethyl-2-hydroxybutanato) oxochromate(V) with bis(hydroxyethyl)amino-tris(hydroxy-methyl)methane (BT). Both epr and kinetic data indicate that the reaction proceeds through a chromium(V) intermediate. Kinetics of formation of the intermediate exhibit a rate saturation at higher [BT] (> 30 mM) indicating a rate law constituting an equilibrium between the parent Cr(V) complex and the bis-tris ligand followed by a pure first order process. The g-value of the intermediate is consistent with a Cr(V) complex in which the BT is coordinated in a bidentate fashion replacing a coordinated hydroxy butanoic acid ligand, affording a mixed ligand complex. The equilibrium step (K = 36 M-1) consists of monodentate coordination by the BT ligand and the limiting first order rate constant (1.9 x 10(-2) s-1) manifests the rate of chelation by the polydentate ligand. The intermediate is converted to the product upon further chelation through the complete displacement of the remaining 2-ethyl-2-hydroxy butanoic acid by a first order process (k = 0.023 s-1). The epr data support a pair of products that are in rapid equilibrium. In these products, BT functions either as a tetra or a penta-dentate ligand coordinating through four or five alkoxy sites. The enthalpy and entropy of activations related to the two chelation steps were found to be 32 +/- 2 kJ/mol and -(1.7 +/- 0.2) x 10(2) J/mol K for the intermediate, and 36 +/- 1 kJ/mol and -(1.5 +/- 0.2) x 10(2) J/mol K for the product. Our data support an associative mechanism for the chelation steps. The Cr(V)-BT product is more stable than the parent complex. The second order disproportionation rate constant for the Cr(V)-BT complex was evaluated to be 0.1 M-1 s-1 compared to 8.0 M-1 s-1 for the parent complex. This is the first example of a chromium(V) complex with a non-macrocyclic ligand coordinating through oxygen donor atoms which is stable in aqueous solution at neutral pH over a long period of time.     

Synthesis and physico-chemical studies of bimetallic alkoxy derivatives of chromium(III) with niobium(V) and tantalum(V)

Reactions of CrCl₃·3thf with KM(OPrⁱ)₆ in 1:3 molar ratios in benzene yield soluble complexes of the type Cr[M(OPrⁱ)₆]₃ (M=Nb or Ta). On heating under vacuum, these complexes tend to disproportionate into Cr(OPrⁱ)₃ and M(OPrⁱ)₅ (M=Nb or Ta). A number of bimetallic alkoxides have also been synthesized by the alcoholysis of Cr[M(OPrⁱ)₆]₃ with alcohols (methanol, ethanol and t-amyl alcohol). The IR, visible, electron spin resonance and magnetic properties of these newly synthesized complexes throw light on the structural features.     

Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex

We synthesized, characterized and studied the anticancer properties of a new water-soluble peroxo niobium complex (K₃[Nb(Asc)(O₂)₃]·4H₂O (Asc = ascorbate anion C₆H₆O₆²⁻))_, as well as that of ascorbic acid, in human leukemic cells. The complex was synthesized and characterized by elemental, IR, Raman, thermogravimetric analysis, detailed NMR and mass spectra analysis. The cytotoxic activity of the complex on HL-60 and K562 human leukemia cell lines has been investigated by assessing vital cellular mechanisms, such as the metabolic activity (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT) and the proliferation capacity (growth curves) of leukemia cells, as well as the structural integrity of cell membrane (trypan blue assay). The complex exerts an increased antiproliferative effect primarily on HL60 human leukemia cells, compared to ascorbic acid alone, as well as an inhibitory effect on necrosis caused by ascorbic acid. Its effect on K562 cells concerns mainly its inhibitory effect upon cell necrosis induced by ascorbic acid alone. Our results support a concentration- and time-dependent enhanced antileukemic effect of the complex, suggesting its significance as a promising tool in the confrontation of leukemia.     

Novel p-tolylimido rhenium(V) complexes incorporating quinoline-2-carboxylate ion - Synthesis, X-ray studies, spectroscopic characterization and DFT calculations

Novel p-tolylimido rhenium(V) complexes trans-[Re(p-NC₆H₄CH₃)X₂(quin-2-COO)(PPh₃)] and cis-[Re(p-NC₆H₄CH₃)X₂(quin-2-COO)(PPh₃)]·MeCN have been obtained in the reactions of [Re(p-NC₆H₄CH₃)X₃(PPh₃)₂] (X = Cl, Br) with quinoline-2-carboxylic acid. The compounds were identified by elemental analysis IR, UV-Vis spectroscopy and X-ray crystallography. The electronic structures of trans- and cis-halide isomers of [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] have been calculated with the density functional theory (DFT) method. Additional information about binding in the compounds [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] with cis- and trans-halide arrangement has been obtained by NBO analysis. The electronic spectra of trans and cis isomers of [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] were investigated at the TDDFT level employing B3LYP functional in combination with LANL2DZ.     

Synthesis, characterization and electrochemical behavior of oxo-bridged (arylimido)[tris(3,5-dimethylpyrazolyl)borato] molybdenum(V) complexes

Reaction of the oxo-molybdenum(V) precursor [MoTp*(O)Cl₂] [Tp* = hydrotris(3,5-dimethyl-1-pyrazolyl)borate] with H₂NC₆H₄R-4 (R = OEt; OPr) in refluxing toluene in the presence of Et₃N afforded the binuclear oxo-bridged oxo(arylimido) molybdenum(V) complexes [Tp*Mo(O)Cl](μ-O)[Tp*Mo(NC₆H₄OR-4)Cl]. Surprisingly, a similar reaction between [MoTp*(O)Cl₂] and C₆H₅NH₂ yielded the previously reported compound [{MoTp*(O)Cl}₂(μ-O)] as the only product. The new compounds were characterized by microanalytical data, mass spectrometry, IR and ¹H NMR spectroscopy. Cyclic voltammetric studies of the new compounds, of the previously reported compounds [Tp*Mo(O)Cl](μ-O)[Tp*Mo(NAr)Cl] (Ar = C₆H₄OMe-4, C₆H₄F-3, C₆H₄Cl-4, C₆H₄Br-4, and C₆H₄I-3), and of [{MoTp*(O)Cl}₂(μ-O)] revealed a reversible one-electron oxidation process that is little affected by the nature of the substituent on the aryl group, whereas it is greatly affected by replacement of the imido ligand with an oxo ligand. The [{MoTp*(O)Cl}₂(μ-O)] compound also shows a one-electron reduction process.     

Synthesis, crystal and molecular structure, spectroscopic and electrochemical studies of trichloro-oxo(4,6-dimethylpyrimidine-2(1H)-thione)(triphenylphosphine oxide)rhenium(V) complex

Reaction of 4,6-dimethylpyrimidine-2(1H)-thione (Me₂pymSH) with mer-[ReOCl₃(Me₂S)(OPPh₃)] synthon in 1:1 molar ratio in refluxing acetone, results in the replacement of the Me₂S ligand to form the mer-[ReOCl₃(Me₂pymSH)(OPPh₃)] species. X-ray diffraction shows that the structure of the title compound consists of monomeric units with a distorted octahedral coordination around the rhenium(V) centre which includes the axial ReO and Re---OPPh₃ bonds, and in which three Cl⁻ ions and a S-monodentate neutral Me₂pymSH ligand act as equatorial ligands. The compound was also characterised using electrochemical measurements and UV–Vis–NIR and IR spectroscopy.     

P NMR and Raman spectroscopic and voltammetric studies on the formation and conversion processes of Keggin-type molybdotungstophosphate(V) and -arsenate(V) complexes in aqueous-organic solvents

The formation conditions of Keggin-type molybdotungstophosphate(V) (PW_xMo_12 − xO₄₀ ³⁻ (PW_xMo_12 − x), x=0-12) and -arsenate(V) (AsW_xMo_12 − xO₄₀ ³⁻ (AsW_xMo_12 − x)) complexes in aqueous-organic solvents were investigated with ³¹P NMR, Raman spectroscopy, and cyclic voltammetry. The conversion processes of the PMo₁₂ and the PW₁₂ anions into the PW_xMo_12 − x anions were also examined and compared with those of the AsMo₁₂ and AsW₁₂ anions into the AsW_xMo_12 − x anions. The mean vibration frequencies of the PW_xMo_12 − x and AsW_xMo_12 − x (x=1-11) complexes were calculated in IR and Raman spectra from those of the PMo₁₂ and PW₁₂, and AsMo₁₂ and AsW₁₂ complexes, respectively.     

Infrared spectroscopic studies of aqueous solutions of dioxouranium(VI) and its hydrolysed products and of in situ electro-generated dioxouranium(V)

Aqueous solutions of dioxouranium(VI) (pH range 0 to 4) give rise to bands at 954 and 938 cm⁻¹ attributable to the v₃(MO₂) stretching modes of the UO₂²⁺ and (UO₂)₂(OH)_2²⁺ cations, respectively. A shoulder at 916 cm⁻¹ is assigned to the v₃(MO₂) mode of hydrolysed dioxouranium(VI) species of higher nuclearity. Infrared spectro-electrochemical studies using a thin-layer reflection-absorption cell have facilitated the study of the reduction of aqueous solutions of dioxouranium(VI) to yield dioxouranium(V) which may be further reduced to uranium(IV). The electrogeneration of dioxouranium(V) is monitored by following the increase in intensity of a band at 914 cm⁻¹ which is present in the spectra at potentials between −0.2 and −0.8 V. The dioxouranium(V) species is predominantly in the form UO₂⁺, which may be in solution or incorporated into an insoluble phase of uranium oxides which deposit onto the working electrode. The U^VO bond length is estimated to be 1.76 Å, 0.03 Å longer than the U^VIO bond in aqueous solution. The maximum concentration of UO₂⁺able to be achieved is highly dependent on the pH and is optimum at pH 3.4. Changes in the pH of the solution under study can be monitored by infrared spectroscopy during the course of the reduction by determining the relative concentrations of hydrolysed dioxouranium(VI) species.     

Optical and electron paramagnetic resonance spectroscopic studies on purine hydroxylase II from Aspergillus nidulans

Purine hydroxylase II from Aspergillus nidulans contains a molybdenum cofactor very similar to that found in a number of other molybdenum-containing hydroxylases. (A. nidulans contains two purine hydroxylases, I and II, related to each other by possession of a common cofactor and overlapping substrate specificity.) Addition of reducing substrates effects bleaching of the visible absorption spectrum of the enzyme, the decrease in absorbance at 450 nm being linearly proportional to that at 550 nm. No increase in absorption at longer wavelengths was observed during such titrations. Electron paramagnetic resonance studies of reduced samples of native and modified enzyme species showed the presence of a number of Mo(V) signals (gav = 1.97), exhibiting H hyperfine coupling, comparable to those in the corresponding enzymes from other sources. The enzyme possesses two non-heme-iron-sulfur centers, one (Fe2S2)I with gav less than 2.0 and the other (Fe2S2)II with gav greater than 2.0. The flavin radical signal observed at pH 7.8 had a linewidth of 1.5 mT, indicating it to be the anionic form FAD- . In this respect purine hydroxylase II is unique among all molybdenum-containing hydroxylases studied to date.     

Synthesis and biological studies of neutral technetium (V) complexes containing NNOS donor sets

Complexation of ligands containing an N₃S donor set has been affected with [^99mTc]. These are part of a ligand series of analogous structures which exhibit similar chemistry and potentially interesting biology. The complexes which have been characterized with [^33mTc]as [TcOL] are neutral and lipophilic and their biological behaviour has been assessed in rats. After HPLC purification of the no-carrier added preparation, brain uptake of the tracers was > 1% at 15 min p.i. Muscle activity was significant with slow blood clearance.     

Synthesis and spectroscopic studies of the aminoglycoside (neomycin)--perylene conjugate binding to human telomeric DNA

Synthesis of a novel perylene-neomycin conjugate (3) and the properties of its binding to human telomeric G-quadruplex DNA, 5'-d[AG3(T2AG3)3] (4), are reported. Various spectroscopic techniques were employed to characterize the binding of conjugate 3 to 4. A competition dialysis assay revealed that 3 preferentially binds to 4, in the presence of other nucleic acids, including DNA, RNA, DNA-RNA hybrids, and other higher-order structures (single strands, duplexes, triplexes, other G-quadruplexes, and the i-motif). UV thermal denaturation studies showed that thermal stabilization of 4 increases as a function of the increasing concentration of 3. The fluorescence intercalator displacement (FID) assay displayed a significantly tighter binding of 3 with 4 as compared to its parent constituents [220-fold stronger than neomycin (1) and 4.5-fold stronger than perylene diamine (2), respectively]. The binding of 3 with 4 resulted in pronounced changes in the molar ellipticity of the DNA absorption region as confirmed by circular dichroism. The UV-vis absorption studies of the binding of 3 to 4 resulted in a red shift in the spectrum of 3 as well as a marked hypochromic change in the perylene absorption region, suggesting that the ligand-quadruplex interaction involves stacking of the perylene moiety. Docking studies suggest that the perylene moiety serves as a bridge that end stacks on 4, making contacts with two thymine bases in the loop, while the two neomycin moieties branch into the grooves of 4.